CLINICAL_TRIALS trial_result · 2017-04-04

Clinical Trial Update: Vaccine Therapy in Treating Patients With Stage I, Stage II, or Stage III Non-small Cell Lung Cancer [Phase 2]

Phase 2 clinical trial results for a vaccine therapy in patients with stage I–III non-small cell lung cancer have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Edward Hirschowitz | Conditions: Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2017-04-04